SHARON CHANDLER: Open Payments
NPI 1427036649 · FARMVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,345 in 61 payments from 20 companies in 2025. Trend: 2023 $1,007 · 2024 $1,248 · 2025 $1,345
Food & beverage: $1,277Education: $68
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $374 |
| PFIZER INC. | 11 | $211 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $174 |
| Novo Nordisk Inc | 4 | $76 |
| Astellas Pharma US Inc | 1 | $68 |
| Dexcom, Inc. | 3 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $57 |
| Boston Scientific Corporation | 1 | $57 |
| Organon LLC | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
Products named: VRAYLAR, Kerendia, NURTEC ODT, UBRELVY, QULIPTA, Dexcom G6 Transmitter, CAPLYTA, General - Pain Management.
Industry payments across VA — which companies pay providers there.
